Arrow-right Camera


New Aids Drug Shows Hope For Hepatitis B

A medicine approved last month to treat AIDS also shows promise against hepatitis B.

The drug, 3TC, suppresses the hepatitis B virus in people with chronic infections, stopping its damage to the liver, researchers reported.

About 1 million Americans are thought to be infected with hepatitis B, which, left untreated, can lead to cirrhosis, liver failure and liver cancer in a small proportion of victims.

Currently, the only treatment for hepatitis B is interferon. This therapy can permanently eliminate the virus in about one-third of patients. It must be injected for four to six months and often has unpleasant side effects, including flu-like symptoms, fatigue and depression.

Unlike interferon, 3TC is given in pill form and carries few side effects.

The study is published in today’s issue of the New England Journal of Medicine. It was financed by Glaxo Wellcome Inc. of Research Triangle Park, N.C., which makes 3TC.

Top stories in Nation/World

Trump backtracks on Syria after talks with French leader

new  One month ago President Donald Trump surprised many, including some in his own administration, by announcing, “We’ll be coming out of Syria, like, very soon. Let the other people take care of it now.” He insisted that the time had come for the U.S. military to shift its focus away from Syria.